Senate overlooked price of cancer drug: experts

Experts have criticised a Senate report on access to innovative  cancer drugs for failing to take into account the impact of drug prices. Published late last year the report titled Availability of new, innovative and specialist cancer drugs in Australia addressed the health burden of cancer on society; the impact on patients of delayed access ...

Already a member?

Login to keep reading.

© 2021 the limbic